ripple digital currency price Top Related searches

In November, Sichuan CPI rose by 0.1% year-on-year, and the price increase of pork and fresh vegetables dropped from the previous month. On December 10, the data released by the Sichuan Survey Corps of the National Bureau of Statistics showed that the consumer price index (CPI) in Sichuan rose by 0.1% year-on-year, and the growth rate dropped by 0.1 percentage point from the previous month. It decreased by 0.7% from the previous month. From January to November, the consumer price of Sichuan residents decreased by 0.1% compared with the same period of last year. In terms of food, the price of food, tobacco and alcohol rose by 1.8% year-on-year in November, and the growth rate dropped by 1.1 percentage points from the previous month. Among them, the prices of pork and fresh vegetables increased by 15.2% and 14.0% year-on-year, respectively, and the growth rate dropped from last month; The price of fresh fruit changed from a year-on-year increase of 3.4% last month to an increase of 2.0%; The prices of eggs and aquatic products decreased by 1.6% and 0.6% respectively. From the ring comparison, the price of food, tobacco and alcohol decreased by 1.9% from 0.3% last month, mainly because the average temperature in November was higher than that in previous years, which was beneficial to the production, storage and transportation of agricultural products, and most fresh food prices were affected by the super-seasonal decline.Kremlin: Actions in the Golan Heights and the buffer zone are unlikely to help stabilize the situation in Syria.Macy's fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors.

Kremlin: (When asked whether the fall of Assad weakened Russia's influence in the Middle East) Military action in Ukraine is a top priority.The Ministry of Finance successfully issued the sixth issue of RMB 6 billion treasury bonds in 2024 in Hong Kong. On December 11th, the Ministry of Finance of People's Republic of China (PRC) issued the sixth issue of RMB 6 billion treasury bonds in 2024 in Hong Kong Special Administrative Region for institutional investors, which was widely welcomed by investors, with a subscription multiple of 3.58 times. Among them, the two-year (additional issuance) is 2 billion yuan, and the issue price is 100.62 yuan, corresponding to the issue interest rate of 1.70%; 3-year (additional issuance) 2 billion yuan, the issue price is 101.28 yuan, corresponding to the issue interest rate of 1.70%; 5-year (additional issuance) 2 billion yuan, the issue price is 102.41 yuan, corresponding to the issue interest rate of 1.80%.R&F Properties announced on the Hong Kong Stock Exchange that the High Court ordered that the hearing of R&F Hong Kong's petition be postponed until December 16, 2024.

CPOPC: The price of palm oil is expected to fluctuate in the range of RM 4,000-5,000 in 2025. It is reported that the Council of Palm Oil Producers (CPOPC) predicts that the price of palm oil may fluctuate in the range of RM 4,000-5,000 per ton in 2025, driven by the stagnant production in major markets, especially Indonesia and Malaysia. Deputy Secretary-General CPOPC pointed out that the current price level around RM5,000 per ton may be temporary, mainly affected by the continuous floods in Malaysia, which boosted the bullish sentiment in the market. Due to the aging plantations, unpredictable weather and limited expansion to new plantations, it is expected that the cessation of production will tighten global supply and further push up prices.Since the release of "Keba Article", the refinancing of the first unprofitable enterprise in Shanghai Stock Exchange has been approved, and Dizhe Medicine announced that the company's private placement plan has been approved by Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article". (science and technology innovation board Daily)The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)